Flossbach von Storch

Superinvestor profile · Rank #20 of 149 tracked managers by reported 13F value · CIK 0001575677 · All profiles
Founded 1998Cologne, GermanyMulti-asset (flagship 'Multiple Opportunities'), guided by the firm's 'Pentagram': diversification, quality, flexibility, solvency, valueKey person: Bert Flossbach and Kurt von Storch (co-founders)
Reported 13F value
$22.1B
Period 2026-06-30 · Filed 2026-08-10
Positions
106
Top 10 = 49.4% of value
Clone CAGR (full window)
+12.7%
2016-10-28 → 2026-10-02 · cumulative +227%
SPY CAGR (same window)
+15.7%
Cumulative +324%
Max drawdown (monthly)
-28%
Month-end values, approximate
Latest-quarter activity
4 new · 7 exited
38 increased · 55 decreased
Hypothetical clone — not this fund's returns. The performance on this page replicates only the long U.S. equity positions disclosed on this manager's Form 13F filings, rebalanced on filing dates at disclosed weights with dividend-adjusted prices. It excludes shorts, bonds, cash, non-U.S. listings, private holdings, leverage and fees. Treat it as a measure of how the disclosed stock picks performed, never as the fund's track record. Evidence: filing-by-filing dossier (PDF) · Methodology (PDF)

Clone performance

2016 2026 — 13F clone — S&P 500 (SPY)
WindowClone CAGRNote
Full window (2016-10-28 → 2026-10-02, 40 filings)+12.68%Cumulative +227.2% vs SPY +324.0%
Trailing 10Y—
Trailing 5Y+7.24%
Trailing 3Y+15.72%
Trailing 1Y+7.53%

Top holdings — 2026 Q2 filing

TickerCompanyWeightReported value
GOOGLAlphabet - Class A7.12%$1.6B
AMZNAmazon.Com5.93%$1.3B
MSFTMicrosoft5.73%$1.3B
BRK.BBerkshire Hathaway B5.68%$1.3B
APHAmphenol4.51%$997M
SCHWCharles Schwab4.47%$988M
TMOThermo Fisher Scientific4.32%$956M
AAPLApple4.21%$930M
ABTAbbott Laboratories4.08%$903M
DHRDanaher3.38%$747M

As reported on the 2026-06-30 Form 13F (filed 2026-08-10). Full holdings and quarter changes: holdings page.

Filing history in this profile

Every clone input traces to one of these SEC filings. 95.5% of the latest filing's reported value is covered by our price history; the remainder is mostly non-U.S. listings, recent IPOs or delisted names and is excluded from the clone.

QuarterSEC accession no.FiledDisclosed CUSIPs
2026Q20001575677-26-0000052026-08-1098
2026Q10001575677-26-0000042026-04-29101
2025Q40001575677-26-0000022026-01-30102
2025Q30001575677-25-0000142025-11-03108
2025Q20001575677-25-0000102025-08-07100
2025Q10001575677-25-0000052025-04-30122
2024Q40001575677-25-0000022025-02-0399
2024Q30001575677-24-0000102024-11-08101
2024Q20001575677-24-0000052024-08-0298
2024Q10001575677-24-0000042024-05-06100
2023Q40001575677-24-0000022024-01-3195
2023Q30001575677-23-0000062023-10-2791
2023Q20001575677-23-0000042023-08-0297
2023Q10001575677-23-0000032023-05-0392
2022Q40001575677-23-0000022023-02-06100
2022Q30001575677-22-0000062022-11-14100
2022Q20001575677-22-0000052022-08-1099
2022Q10001575677-22-0000042022-05-11101
2021Q40001575677-22-0000032022-02-04102
2021Q30001575677-21-0000052021-11-0497
2021Q20001575677-21-0000042021-08-0294
2021Q10001575677-21-0000032021-05-0489
2020Q40001575677-21-0000022021-02-0983
2020Q30001575677-20-0000072020-11-0584
2020Q20001575677-20-0000052020-08-1087
2020Q10001575677-20-0000042020-05-1192
2019Q40001575677-20-0000022020-02-1195
2019Q30001575677-19-0000082019-11-0889
2019Q20001575677-19-0000062019-08-0690
2019Q10001575677-19-0000052019-05-0289
2018Q40001575677-19-0000032019-02-0589
2018Q30001575677-18-0000072018-11-0592
2018Q20001575677-18-0000052018-08-0889
2018Q10001575677-18-0000032018-05-0489
2017Q40001575677-18-0000022018-02-0787
2017Q30001575677-17-0000062017-11-0983
2017Q20001575677-17-0000052017-07-2782
2017Q10001575677-17-0000042017-05-0481
2016Q40001575677-17-0000022017-01-3083
2016Q30001575677-16-0000112016-10-2875

Background (founded / HQ / style) source: http://www.flossbachvonstorch.de/en/about-us/company-profile — German, bank-independent, owner-managed asset manager and one of Europe's largest independent firms (roughly EUR 60-70 billion AUM). Both founders are former Goldman Sachs private bankers. Its U.S. Form 13F covers only the U.S.-listed equity sleeve of a predominantly multi-asset business.